Cargando…
Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma
BACKGROUND: Lung squamous cell carcinoma (LUSC) is an important subtype of non-small cell lung cancer. Its special clinicopathological features and molecular background determine the limitations of its treatment. A recent study published on Science defined a newly regulatory cell death (RCD) form –...
Autores principales: | Zhang, Yangyang, Zhou, Jia, Li, Hong, Liu, Yaobang, Li, Jinping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258956/ https://www.ncbi.nlm.nih.gov/pubmed/37308925 http://dx.doi.org/10.1186/s12890-023-02490-9 |
Ejemplares similares
-
Cuproptosis predicts the risk and clinical outcomes of lung adenocarcinoma
por: Hu, Qin, et al.
Publicado: (2022) -
A risk prognostic model for patients with esophageal squamous cell carcinoma basing on cuproptosis and ferroptosis
por: Li, Jianan, et al.
Publicado: (2023) -
Cuproptosis-related gene subtypes predict prognosis in patients with head and neck squamous cell carcinoma
por: Wang, Chi, et al.
Publicado: (2023) -
Exosomes Derived from Tumor Cells Initiate Breast Cancer Cell Metastasis and Chemoresistance through a MALAT1-Dependent Mechanism
por: Tao, Shuang, et al.
Publicado: (2022) -
Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma
por: Zhou, Wolong, et al.
Publicado: (2023)